| 别名 | ; |
5,8-二溴-2,3-双(4-甲氧基苯基)喹喔啉
5,8-Dibromo-2,3-bis(4-methoxyphenyl)quinoxaline （订货以英文为准）
编号：D155121
CAS号：162967-90-0
分子式：C22H16N2O2BR2
分子量：500.18
| 产品名称 | 5,8-Dibromo-2,3-bis(4-methoxyphenyl)quinoxaline |
| 中文名称 | 5,8-二溴-2,3-双(4-甲氧基苯基)喹喔啉 |
| CAS号 | 162967-90-0 |
| 分子式（M.F.） | C22H16N2O2BR2 |
| 分子量（M.W.） | 500.18 |
| Reaxys-RN | 8933079 |
技术规格
| Background: | Responds to activation by environmental stress, pro-inflammatory cytokines and lipopolysaccharide (LPS) by phosphorylating a number of transcription factors, such as ELK1 and ATF2 and several downstream kinases, such as MAPKAPK2 and MAPKAPK5. Plays a critical role in the production of some cytokines, for example IL-6. May play a role in stabilization of EPO mRNA during hypoxic stress. Isoform Mxi2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform Exip may play a role in the early onset of apoptosis. |
| Applications: | WB, IHC |
| Name of antibody: | MAPK14 (Phospho-Tyr182) |
| Immunogen: | Synthetic peptide of human MAPK14 (Phospho-Tyr182) |
| Full name: | mitogen-activated protein kinase 14 (Phospho-Tyr182) |
| Synonyms： | RP1-179N16.5; CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; P38alpha |
| SwissProt: | Q16539 |
| IHC positive control: | Human breast carcinoma |
| IHC Recommend dilution: | 50-100 |
| WB Predicted band size: | 43 kDa |
| WB Positive control: | Hela cells treated with UV |
| WB Recommended dilution: | 500-1000 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 411.90
C196274-5g
党沛 
